Digirad nets clearance for cardiac reconstruction software

Digirad, a diagnostic imaging system developer, has received FDA 510(k) marketing clearance for its new nSPEED reconstruction software.

The Poway, Calif.-based company said that with nSPEED its Digirad Cardius solid-state dedicated cardiac systems can perform cardiac SPECT imaging procedures in as little as three minutes or with one-half the required pharmaceutical dosages.

Digirad said the reconstruction software can be used in its imaging systems for SPECT procedures at either half-time and/or half count densities with parallel and non-parallel hole collimators.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.